Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apeloa Jiayuan Pharmaceutical is a prominent subsidiary of Apeloa Pharmaceutical, specializing in the contract development and manufacturing (CDMO) of active pharmaceutical ingredients (APIs) and advanced intermediates. Based in the Hengdian industrial zone of China, the company operates large-scale manufacturing facilities that adhere to rigorous international quality standards, including US FDA and EU GMP certifications. Their core business focuses on small molecule synthesis, offering services that span from early-stage process development to full commercial production. Apeloa Jiayuan serves a global clientele, providing critical components for therapies in cardiovascular, anti-infective, and oncology sectors. The company is a key driver of its parent organization's reputation as a reliable partner in the global pharmaceutical supply chain. It leverages advanced chemical technologies such as high-pressure hydrogenation and cryogenic reactions to deliver high-quality pharmaceutical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apeloa Jiayuan Pharmaceutical.